Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
09/01/2010 | CN101817780A Preparation method of pyridine-2-formaldehyde |
08/31/2010 | US7786328 e.g. benzoic acid 2-[4-dimethylamino-4-(3-methyl-benzyl)-cyclohexylcarbamoyl]-benzyl ester; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases |
08/31/2010 | US7786316 Metalloprotein inhibitors |
08/31/2010 | US7786305 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
08/31/2010 | US7786177 Phenylalanine enamide derivatives |
08/31/2010 | US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease |
08/31/2010 | US7786147 used for the treatment of Parkinson's disease, Huntington disease, Alzheimer's disease, amyotrophic lateral sclerosis, spinal muscular atrophy, ataxia, Pick's disease, Pick's disease, vision defects, Cruetzfelt-Jacob syndrome or Alzheimer's disease |
08/31/2010 | US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example |
08/31/2010 | US7786121 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals |
08/31/2010 | US7786044 e.g.4-Amino-6-(4-chlorophenyl)-5-fluoro-3-vinylpyridine-2-carboxylic acid; 4-Acetylamino-6-(4-chloro-2-fluoro-3-methoxyphenyl)-3-trimethylsilanylethynylpyridine-2-carboxylic acid methyl ester; |
08/31/2010 | US7786043 e.g.2-(5-chloro-6-phenylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline; 4-[3-methyl-6-(5,6,7,8-tetrahydroquinazolin-2-yl)pyridin-2-yl]benzonitrile |
08/31/2010 | US7785678 positive dielectric anisotropy; electrooptics; chemical, electrical resistance |
08/31/2010 | CA2574600C Pyridine derivatives |
08/31/2010 | CA2549558C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
08/26/2010 | WO2010096722A1 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors |
08/26/2010 | WO2010094659A1 Amine or amino alcohols as glyt1 inhibitors |
08/26/2010 | WO2010094644A1 Substituted pyridine derivatives and their medical use |
08/26/2010 | WO2010094169A1 Magnesium-cobalt based catalyst for synthesizing pyridine base from formaldehyde, acetaldehyde and ammonia and preparation method thereof |
08/26/2010 | WO2010094168A1 Ti-containing catalyst for synthesizing pyridine bases by reacting ammonia, formaldehyde and acetaldehyde and its preparation method |
08/26/2010 | WO2010076033A9 Toluidine sulfonamides and their use |
08/26/2010 | WO2010066682A4 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders |
08/26/2010 | WO2010019701A3 Diaryl urea derivatives |
08/26/2010 | WO2010003614A3 Transfection solution |
08/26/2010 | US20100217006 Inhibitor Of Ischemic Disorders |
08/26/2010 | US20100216849 Biphenylcarboxamides |
08/26/2010 | US20100216818 Inhibitors of Post-Amadori Advanced Glycation End Products |
08/26/2010 | US20100216758 Pyridone Compounds |
08/26/2010 | US20100216638 Herbicidally active bicyclic 1,3-dione compounds |
08/26/2010 | US20100216252 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging |
08/26/2010 | US20100215661 Nicotinamide derivates useful as p38 inhibitors |
08/26/2010 | US20100215652 Nicotinamide derivates useful as p38 inhibitors |
08/26/2010 | US20100215574 Process for producing an injectable medicament preparation |
08/26/2010 | US20100213826 Material for organic photoelectric device, and organic photoelectric device thereby |
08/26/2010 | CA2752807A1 Amine or amino alcohols as glyt1 inhibitors |
08/25/2010 | EP2220045A1 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor |
08/25/2010 | EP2220044A1 P38 map kinase inhibitors |
08/25/2010 | EP2220043A1 Crystalline form of an antimalarial compound |
08/25/2010 | EP2220042A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
08/25/2010 | EP2220030A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
08/25/2010 | EP2220029A1 Novel compounds |
08/25/2010 | EP2069302B1 Substituted pyridylmethyl bicyclocarboxyamide compounds |
08/25/2010 | EP1366016B1 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
08/25/2010 | CN1997619B Phenyl derivatives comprising an acetylene group |
08/25/2010 | CN101812699A Method for simultaneously preparing tetrachloropyridine and diglycolic acid in cathode and anode chambers |
08/25/2010 | CN101812093A One-dimensional micron or submicron material of polypyridine platinum complex as well as preparation method and application thereof |
08/25/2010 | CN101812084A Rare earth metal amine compound containing aromatic amine methylene pyrrole ligand, preparation method and application thereof |
08/25/2010 | CN101812016A Method for preparing 6-methylnicotinic acid etoricoxib intermediate and ester thereof |
08/25/2010 | CN101812015A Preparation method of flupirtine |
08/25/2010 | CN101402600B Process for producing vitamin B6 |
08/25/2010 | CN101302188B Bidentate ligand 4,4'- bis (hydroxymethyl)-2,2'dipyridine, preparation thereof and application to polyketone synthesis |
08/25/2010 | CN101157652B Antitumor activity bipyridine methyl amine compound and preparation method thereof |
08/24/2010 | US7781960 Metal complex compound and organic electroluminescent element using the same |
08/24/2010 | US7781628 in which an organic thin film layer comprising a single layer or plural layers including at least a light emitting layer is sandwiched between a cathode and an anode; high luminous efficiency |
08/24/2010 | US7781593 CB1 cannabinoid receptor antagonists/inverse agonists; 5-(4-chloro-phenyl)-N-((1R,2R)-2-hydroxy-cyclohexyl)-6-(3-methoxy-propyl)-nicotinamide for example; eating disorders, obesity, diabetes type II or non insulin dependent diabetes (NIDD), neuroinflammation, diarrhea, drug abuse |
08/24/2010 | US7781592 Thione derivative, method for the preparation thereof, and pharmaceutical composition containing the same |
08/24/2010 | US7781470 Aminodicarboxylic acid derivatives having pharmaceutical properties |
08/24/2010 | US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents |
08/24/2010 | US7781458 Derivatives of pyridine and quinoline |
08/24/2010 | US7781454 Substituted indazoles, benzotriazoles, and related bicyclic compounds; HIV (human immunodeficiency virus) reverse transcriptase inhibitors; delays onset of AIDS or AIDS related complex |
08/24/2010 | CA2423103C N-acylsulfonamide apoptosis promoters |
08/19/2010 | WO2010093890A2 Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides) |
08/19/2010 | WO2010093889A2 Solid forms of 2-(2, 4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide |
08/19/2010 | WO2010093849A2 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions |
08/19/2010 | WO2010093595A1 Fungicidal 2-pyridones |
08/19/2010 | WO2010092180A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy |
08/19/2010 | WO2010092043A1 Phenoxy acetic acid derivatives |
08/19/2010 | WO2010075280A3 Coumarin-based compounds for the treatment of alzheimer's disease and cancer |
08/19/2010 | WO2010057922A4 Curable composition comprising a thermolatent base |
08/19/2010 | WO2010047774A3 Inhibitors of mycobacterium tuberculosis malate synthase, methods of marking and uses thereof |
08/19/2010 | US20100210837 Pactamycin biosynthetic gene cluster |
08/19/2010 | US20100210694 New no-donor aspirin derivatives |
08/19/2010 | US20100210693 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
08/19/2010 | US20100210653 Novel Compounds, Their Preparations and Use |
08/19/2010 | US20100210603 Novel sulfonamide inhibitors of aspartyl protease |
08/19/2010 | US20100210593 Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators |
08/19/2010 | DE102009055319A1 Kristalline Formen von [2-Amion-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäure-ethylester Crystalline forms of [2-Amion-6- (4-fluoro-benzylamino) -pyridin-3-yl] -carbamic acid ethyl ester |
08/19/2010 | CA2752544A1 Solid forms of 2-(2, 4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide |
08/19/2010 | CA2752190A1 Small molecule bradykinin b1 receptor antagonists |
08/19/2010 | CA2751260A1 Phenoxy acetic acid derivatives |
08/19/2010 | CA2750793A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy |
08/18/2010 | EP2218711A1 Oxime ether derivative and bactericide for agricultural and horticultural use |
08/18/2010 | EP2217571A2 Novel precursors |
08/18/2010 | EP2217570A2 Synthesis of diaminodinitropyridine and diaminodinitrobenzene |
08/18/2010 | EP2217566A1 Bis-(sulfonylamino) derivatives in therapy 066 |
08/18/2010 | EP2217565A1 Compounds which modulate the cb2 receptor |
08/18/2010 | EP2217229A1 Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof |
08/18/2010 | EP1940786B1 Biphenyl derivatives and their use in treating hepatitis c |
08/18/2010 | EP1692109B1 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
08/18/2010 | EP0956865B2 MEDICINES COMPRISING Rho KINASE INHIBITOR |
08/18/2010 | CN101809014A Method for producing pyrazol-3-yl-benzamide derivative |
08/18/2010 | CN101808996A Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
08/18/2010 | CN101808995A Novel glucokinase activators and methods of using same |
08/18/2010 | CN101808994A Compounds and methods for kinase modulation, and indications therefor |
08/18/2010 | CN101808993A biocidal mixtures |
08/18/2010 | CN101808992A 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
08/18/2010 | CN101808986A Imidate compound and use thereof for pest control |
08/18/2010 | CN101805326A 1,3-diaryl-3-aromatic amino-1-propanol compound and preparation method and application thereof |
08/18/2010 | CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors |
08/18/2010 | CN101805286A Method for synthesizing midbody sulfamide of nicosulfuron |
08/18/2010 | CN101805285A Nicotinic acid-contained curcumin ester derivative and preparation method and application thereof |